In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Toviaz, Fesoterodine fumarate Drug Master File in Korea (Toviaz, Fesoterodine fumarate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Toviaz, Fesoterodine fumarate. The MFDS reviews the Toviaz, Fesoterodine fumarate KDMF as part of the drug registration process and uses the information provided in the Toviaz, Fesoterodine fumarate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Toviaz, Fesoterodine fumarate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Toviaz, Fesoterodine fumarate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Toviaz, Fesoterodine fumarate suppliers with KDMF on PharmaCompass.